Biomarkers of Renal Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBiorek S.R.L.
About this trial
The aim of the present study is the identification, in liquid biopsies, of a new molecular panel able to discriminate renal cancer patients from controls, to discriminate patients with a malignant lesion from those with a benign mass, to determine aggressiveness of RCC, and to differentiate the most common histological subtypes of RCC (clear cell, papillary 1, papillary 2, and chromophobe).
This new molecular panel will be combined with clinical parameters to provide a screening test and to improve the accuracy and specificity of diagnosis, prognosis, and histological classification of renal cancer.
Eligibility criteria
Qualifiers
Men and women over 18 years of age
Diagnosis of first episode of renal mass
Caucasian race
Signed, informed consent
Disqualifiers
Any other concomitant cancer or history of active cancer in the last 5 years
Oncological genetic syndrome
Previous history of renal tumour
Urothelial cancer
Trial design
Treatments tested in this trial
- Not listed
Trial groups
1,000 Participants
are grouped into 2 trial groupsSponsors and collaborators
Source ClinicalTrials.gov